One of the best characterized tests for diagnosis of neurocysticercosis (NCC) is the 2 enzyme-linked immunoelectrotransfer blot (EITB) developed at CDC that uses lentil-3 lectin purified glycoproteins (LLGP) extracted from T. solium cysticerci. Although the 4 test is very reliable, purification of the LLGP antigens has been difficult to transfer to 5 other laboratories because of the need for expensive equipment and technical expertise. 6
INTRODUCTION

18
Diagnosis of neurocysticercosis (NCC), caused by the larval stages of Taenia 19 solium, is reliably established using results from both imaging and serological tests. 20
Guidelines proposed for diagnosis of presumptive NCC (1, 2) define cases as definitive, 21 probable, or possible based on CT or MRI findings, exposure risk, and serological results. 22
These guidelines specifically define the lentil lectin-bound glycoprotein enzyme-linked 23 immunotransfer blot (LLGP-EITB) as the serological reference standard for diagnosis of 24
NCC(3). 25
The LLGP-EITB is an immunoblot method that detects antibodies to one or more 26 of seven lentil lectin-bound glycoproteins, which are present in the soluble fraction of an 27 extract of T. solium cysts. In patients with multiple, enhancing intracranial lesions, the 28 LLGP-EITB is 100% specific and 95% sensitive using serum or CSF, respectively (3-6). 29
The original description and evaluation of the LLGP-EITB was performed using sera from 30 biopsy proven cases of NCC, most with multiple lesions, as detected by skeletal 31 radiographs and reported a sensitivity of 98% and specificity of 100% (3). Continued 32 monitoring of the test performance, compared with clinical findings using newer imaging 33 techniques, such as CT and MRI, revealed that the sensitivity of the assay was lower, 34 between 50 to 80%, in cases with a single lesion or calcified cysts (6-10). The specificity 35 of the LLGP-EITB has been remarkable, essentially 100%, with only rare anecdotal 36 reports of false-positive results (11) (12) (13) . 37
Although the LLGP-EITB is an excellent test, purification of the LLGP from cysts 38 collected from naturally infected pigs has been difficult to standardize and the 39 polyacrylamide gel system used for the LLGP-EITB assay has been difficult to establish 40 in other laboratories. Greater availability of simple and reliable diagnostics for NCC is 41 on July 8, 2017 by guest http://jcm.asm.org/ Downloaded from anticipated through the use of recombinant or synthetic protein antigens. Therefore, we 42 systematically purified and cloned the diagnostic glycoproteins in the LLGP fraction (14-43 16) . We found that the seven diagnostic proteins comprise three distinct antigenic protein 44 families: the gp50, gp24, and 8-kDa families. We chose representative recombinant or 45 synthetic forms from each of the three antigen families and incorporated these into an 46 immunoblot test (recombinant EITB) for the clinical diagnosis of NCC. 47
MATERIALS AND METHODS 48
Chemicals and Reagents 49
All reagents were reagent grade or better and unless otherwise noted were obtained 50 from Mallinckrodt (St. Louis, MO). The horseradish peroxidase labeled goat anti-human 51
IgG secondary antibody was prepared at CDC (17). 52
Serum Samples 53
Sera for assay optimization. A serum pool constructed by pooling 5 serum 54 samples from human cases with confirmed cysticercosis was used for optimizing both the 55 assay and as a positive assay control. This pool contained antibodies that reacted with all 56 seven of the diagnostic proteins in the LLGP-EITB. A serum sample from a human case 57 of alveolar echinococcosis (Echinococcus multilocularis) was used as a heterologous 58 infection serum control. A negative serum pool was constructed from 5 serum samples 59 from United States residents with no reported history of international travel. 60
Serum panels for determinations of diagnostic sensitivity and diagnostic 61 specificity. A total of 249 serum specimens from persons with defined NCC were 62 collected by the Instituto Nacional de Ciencias Neurologicas, Lima, Peru, from patients 63 presenting with clinical symptoms of NCC and provided to CDC for the initial evaluation 64 studies. The definitive diagnosis of NCC was confirmed by CT or MRI brain imaging (1, 65 2). Serum samples from the NCC cases were sorted into three categories based on the 66 imaging data from each patient: sera from patients with 2 or more viable cysts (n = 107) 67 (these included sera from patients with multiple viable cysts or a racemose cyst), patients 68 with a single, viable cyst (n = 52), and patients with calcified and/or degenerated cysts (n 69 = 90). Cases with a single lesion and that were seronegative were still considered 70 by stool examination and all were negative. In addition, a panel of sera collected from 79 patients with heterologous infections (n = 210) was used. All of these serum samples 80
were collected in regions where transmission of cysticercosis/taeniasis does not occur, 81 except the sera from persons with T. saginata taeniasis, which were collected in Peru. 82
Differentiation of T. solium and T. saginata was made after examining the proglottids or 83
by . 84
Another unique set of serum samples from NCC patients were tested in Lima, 85
Peru. The 239 defined sera were collected from 119 patients with 2 or more viable cysts 86 patients, 84 patients with a single viable cyst, and 36 patients with other stages of NCC. 87
Recombinant and synthetic T. solium protein antigens 88
Recombinant rGP50 was expressed in Sf21/Sf9 cells and the hydrophilic 89 extracellular domain of T24, rT24H, was expressed in the Tni cell line, using baculovirus 90 expression systems, as described previously (15, (Whatman Protran BA83, Cat. # 10 541 103, 0.2μm pore size) as described previously 97 (22). The blots were cut into 2.5 mm strips and stored in PBS/0.1% NaN 3 at 4°C prior to 98 use. Sera were tested and specific antibodies were detected as described previously (3, 99 22). Blot strips and the initial experiments to establish the optimal concentration of each 100 recombinant protein/synthetic peptide were prepared using 5-22.5% polyacrylamide gels 101 that were made in our lab at CDC (22). To see if the proteins/peptide could be separated 102 adequately using commercially prepared gels, we used 15% and 4-22% gradient gels from 103
Bio-Rad (Hercules, CA). 104
Data Analysis 105
Agreement between the LLGP-EITB and recombinant EITB results was 106 determined using Cohen's kappa statistic (23). We used the following scale to interpret An initial set of experiments was conducted to determine the optimal concentration 112 of each individual antigen for the recombinant EITB. Each of the protein antigens, rGP50, 113 rT24H, and sTsRS1, was diluted serially and analyzed separately, using SDS-PAGE and 114 immunoblot analysis. The blots were incubated with the pooled cysticercosis serum, the 115 echinococcosis serum, or the pooled normal serum. The optimal concentration of each 116 antigen was determined visually by choosing the concentration that gave the greatest 117 specific reactivity, observed by comparing the reactivity with the cysticercosis serum to 118 reactivity with the echinococcosis serum and the pooled normal serum. The optimal 119 concentrations of the antigens were determined: rGP50, 0.2 ng/mm; rT24H, 2.5 ng/mm; 120 and sTsRS1, 10 ng/mm (data not shown). 121
The 3 antigens were mixed together at their respective final optimal concentrations 122 and separated using SDS-PAGE. The pooled recombinant proteins, rGP50 and rT24H and 123 the synthetic peptide, sTSRS1, were separated on 5-22.5% polyacrylamide gels made in-124 house ( Figure 1 ). The three antigens were successfully resolved when the mixture of 125 recombinant proteins/synthetic peptide was separated using commercially prepared 126 polyacrylamide gels (Figure 2) . 127
The sensitivity of the recombinant EITB for diagnosing NCC was assessed at two 128 sites using two different serum batteries: at the CDC in Atlanta, GA, USA and at the 129 Instituto Nacional de Ciencias Neurologicas, Lima, Peru. When the data from both sites 130 are considered, the combination of all three antigens proved to be sensitive than any single 131 antigen alone for detecting cases of NCC with 2 or more viable cysts (Table 2) , although 132 the sensitivity was excellent (>95%) for all combinations of antigens and except TSRS1 133 alone, which had a sensitivity for detecting NCC cases of 85% or 75%, depending on the 134 on July 8, 2017 by guest http://jcm.asm.org/ Downloaded from serum battery examined. When the sensitivity of testing for the individual antigens was 135 evaluated, rT24H performed better than rGP50, than TSRS1 (rT24H.rGP50>TSRS1). 136 Similar patterns of reactivity occurred for sera from NCC patients with a single viable cyst 137 or degenerate or calcified cysts only (Tables 2 and 3) . 138
The specificity of the recombinant EITB for diagnosing NCC was also evaluated 139 using a panel of 401 serum samples (Table 1) . Sera for the specificity analysis were 140 collected from healthy individuals (n =191) or patients with heterologous infections (n = 141 210). The specificity of the recombinant EITB using the recombinant/synthetic antigens, 142 either alone or in combination, was greater than or equal to 98% (Table 2) . 143
We compared reactivity in the recombinant EITB to the currently accepted 144 standard for laboratory diagnosis, the LLGP-EITB (Tables 2 and 4 We also compared reactivity with the rT24H antigen to native gp42 and gp24. 151 Similar levels of reactivity were seen using sera from cases with two or more viable cysts 152 with the recombinant and the native proteins (Table 4) This study demonstrates that recombinant proteins can replace the native LLGP 158 antigens for diagnosis of NCC with comparable sensitivity and specificity when used in an 159 immunoblot format. The sensitivity of the recombinant EITB was similar to that of the 160 native LLGP-EITB when all 3 antigens were used in combination and when rT24H was 161 used in any combination or alone. The specificity of the new recombinant EITB was also 162 similar to that of the LLGP-EITB. Since its introduction over 30 years ago, the specificity 163 of the LLGP-EITB has remained exquisite, very near 100%, although there have been a 164 few anecdotal reports of false positive results mainly associated with reactivity to the 165 native gp50 protein alone (11-13). In one study, only 2 of 13 patients with antibodies to 166 only native gp50 were associated with a clinical diagnosis of NCC; seven cases had other 167 final diagnoses (12) suggesting that reactivity to gp50 alone should be interpreted with 168 caution. Similarly in this study, the inclusion of rGP50 increases sensitivity in detecting 169 patients with single lesions on CT, however the overall specificity of the assay is reduced 170 when rGP50 is included. In this study cross reactivity was seen in patients with 171 schistosomiasis. This may represent cross-reactivity or may represent undetected 172 exposure to T. solium in these patients. This observation could have implications in 173 regions here the two diseases are endemic. 174 sTSRS1, instead of one of the other 8 kDa peptides, was specifically selected for 175 use in this study based on data from previous studies. When sTSRS1 was used in an 176 immunoblot format, sTSRS1 detected 96% of NCC cases with 2 or more viable cysts (25). 177
In another study that evaluated the performance of several 8 kDa proteins in a MAPIA 178 assay, sTSRS1 showed at sensitivity of 81% (26) (16), suggesting that a large percentage of NCC cases would be 191 detected using a recombinant form of GP24. In this study, the rT24H antigen alone had a 192 sensitivity (99%) and specificity (100%) for NCC cases with more than one viable cyst, 193 which was comparable to the LLGP-EITB using native proteins. In multiple assay 194 formats, rT24H alone has performed as well or better than the combination of antigens 195 (16, 26, 28) . Based on the data from this and other studies using the recombinant derived proteins, we propose that rT24H can be used alone and should be an option for 197 laboratories and manufactures to consider, since its use alone may simplify result 198 interpretation and reduce the cost of the assay. Although rT24H can be used alone for 199 most applications, particularly diagnostics, it may be useful to include a representative 200 antigen from all three antigen families in certain situations, such as epidemiological 201 studies to stratify parasite load in pigs (31, 32) . 
